- 米国企業
- ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc.CLPT
時価総額
$3億
PER
2012年 12月31日 | 2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
Net loss | -5,707,136 | -7,086,274 | -4,524,732 | -8,449,246 | -8,069,895 | -7,167,353 | -6,163,469 | -5,539,790 | -7 | -14 | -16 |
Allowance for doubtful accounts | - | - | - | - | - | - | - | - | - | 0 | -0 |
Depreciation and amortization | 416,970 | 426,183 | 377,261 | 211,946 | 155,707 | 116,454 | 109,439 | 143,604 | 0 | 0 | 0 |
Share-based compensation | 2 | 1 | 880,765 | 2 | 959,585 | 1 | 1 | 799,111 | 1 | 2 | 4 |
Paid-in-Kind Interest | - | - | - | - | - | - | - | - | 0 | 0 | - |
Amortization of Debt Issuance Costs and Discounts | 2 | 143,418 | 330,987 | 471,146 | 424,431 | 426,358 | 562,529 | 729,287 | 1 | 0 | 0 |
Depreciation, Amortization and Accretion, Net | - | - | - | - | - | - | - | 106,956 | 0 | 1 | 1 |
Accretion of discounts on short-term investments | - | - | - | - | - | - | - | - | - | - | 0 |
Accounts receivable | 43,852 | 324,920 | -301,403 | 749,094 | -352,100 | 83,472 | 284,481 | -143,979 | 1 | 1 | 0 |
Inventory, net | 270,686 | 309,551 | 345,988 | -68,626 | -72,342 | 469,922 | -122,220 | 1 | 0 | 2 | 4 |
Prepaid expenses and other current assets | 43,461 | 63,997 | -145,650 | 68,029 | 37,748 | 57,731 | 20,957 | 143,543 | -0 | 0 | 1 |
Other assets | -16,581 | 2,550 | - | -9,811 | - | 999 | 10,897 | -14,965 | -0 | 0 | 0 |
Accounts payable and accrued expenses | -2,738,727 | -695,343 | 1 | -436,420 | 178,419 | -512,362 | -284,322 | 1 | -0 | 1 | 2 |
Lease liability | - | - | - | - | - | - | - | - | - | - | -1 |
Deferred revenue | - | - | - | - | - | - | - | 863,791 | -0 | 0 | 1 |
Net cash flows from operating activities | -7,433,816 | -7,777,931 | -7,250,303 | - | - | -5,992,511 | -4,630,592 | -2,849,515 | -8 | -13 | -16 |
Purchases of property and equipment | 127,453 | 74,469 | 48,129 | 76,883 | 101,002 | 26,752 | 63,490 | 10,190 | 0 | 0 | 0 |
Acquisition of licensing rights | - | 100,000 | - | - | - | - | - | - | - | - | 1 |
Purchase of short-term investments | - | - | - | - | - | - | - | - | - | - | 22 |
Proceeds from maturities of short-term investments | - | - | - | - | - | - | - | - | - | - | 12 |
Net cash flows from investing activities | -127,453 | -174,469 | -48,129 | - | - | -26,752 | -63,490 | -160,190 | -0 | -0 | -11 |
Proceeds from Issuance of Common Stock | - | - | - | - | - | - | - | - | - | 47 | - |
Proceeds from stock option and warrant exercises | - | - | - | - | - | - | - | - | - | 0 | 0 |
Proceeds from issuance of common stock under employee stock purchase plan | - | - | - | - | - | - | - | - | - | 0 | 0 |
Payments for taxes related to net share settlement of equity awards | - | - | - | - | - | - | - | - | - | 1 | 0 |
Net cash flows from financing activities | 9 | 10 | 13 | - | - | 12 | -1,494,616 | 6 | 23 | 47 | 0 |
Net change in cash and cash equivalents | - | - | - | - | - | - | - | - | 14 | 34 | -26 |
Interest | - | - | - | - | - | 348,528 | 210,722 | 316,558 | 2 | 1 | 1 |